Viewing Study NCT04291105


Ignite Creation Date: 2025-12-25 @ 3:26 AM
Ignite Modification Date: 2026-01-10 @ 1:34 AM
Study NCT ID: NCT04291105
Status: RECRUITING
Last Update Posted: 2025-03-26
First Post: 2020-02-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
Sponsor: Vyriad, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module